Apellis Pharmaceuticals
APLS
APLS
246 hedge funds and large institutions have $2.28B invested in Apellis Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 108 increasing their positions, 69 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
246
Holders Change
-8
Holders Change %
-3.15%
% of All Funds
3.3%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
43
Increased
108
Reduced
69
Closed
49
Calls
$56.2M
Puts
$12.6M
Net Calls
+$43.6M
Net Calls Change
+$36.9M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
$46.8M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$121M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
$103M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$82M |
| 5 |
Amundi
Paris,
France
|
$28.6M |
